Salarius Pharmaceuticals Adds Fox Chase Cancer Center To Ongoing Trial Of Seclidemstat As A Treatment For Ewing Sarcoma And FET-Rearranged Sarcomas

Press/Media

PeriodJul 13 2021

Media coverage

16

Media coverage